首页|曲克芦丁联合双联抗血小板方案对急性脑梗死患者神经功能及预后的影响

曲克芦丁联合双联抗血小板方案对急性脑梗死患者神经功能及预后的影响

扫码查看
目的 探讨曲克芦丁联合双联抗血小板方案治疗急性脑梗死(ACI)患者的临床效果.方法 选取2020年8月至2023年2月我院收治的70例ACI患者,随机分为两组各35例.在常规治疗基础上,对照组给予双联抗血小板药物(阿司匹林+氯吡格雷)治疗,治疗组在对照组基础上给予曲克芦丁治疗.比较两组的临床疗效、神经功能以及预后质量.结果 治疗组的总有效率为94.29%,高于对照组的77.14%(P<0.05).治疗后,治疗组的NIHSS评分低于对照组,BI评分高于对照组(P<0.05).结论 曲克芦丁联合双联抗血小板方案治疗ACI患者的效果显著,能够有效促进患者神经功能恢复,改善预后.
Impact of Troxerutin Combined with Dual Antiplatelet Regimen on Neurological Function and Prognosis of Patients with A-cute Cerebral Infarction
Objective To explore the clinical effect of troxerutin combined with dual antiplatelet regimen in the treatment of patients with acute cerebral infarction(ACI).Methods 70 ACI patients admitted to our hospital from August 2020 to February 2023 were selected and randomly divided into two groups,with 35 cases in each group.On the basis of conventional therapy,the control group was treated with dual antiplatelet drugs(aspirin+clopidogrel),and the treatment group was treated with troxerutin on the basis of the control group.The clinical efficacy,neurological function and prognosis quality were compared between the two groups.Results The total effective rate of the treatment group was 94.29%,higher than 77.14%of the control group(P<0.05).After treatment,the NIHSS score of the treatment group was lower than that of the control group,and the BI score was higher than that of the control group(P<0.05).Conclusions Troxerutin combined with dual antiplatelet regimen in the treatment of ACI patients has significant effect,which can effectively promote the recovery of neurological function and improve the prognosis of patients.

Acute cerebral infarctionTroxerutinAspirinClopidogrelNeurological functionPrognosis

高应亮、江远义

展开 >

江西省鄱阳县人民医院急诊科,江西上饶 333100

急性脑梗死 曲克芦丁 阿司匹林 氯吡格雷 神经功能 预后

2024

临床医学工程
国家医疗保健器具工程技术研究中心

临床医学工程

影响因子:0.193
ISSN:1674-4659
年,卷(期):2024.31(6)
  • 7